Chemed (CHE) Share-based Compensation (2009 - 2026)

Chemed's Share-based Compensation history runs 18 years deep, the most recent figure standing at $9.2 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 1.74% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $1.3 million (down 96.01% YoY), while the FY2025 annual figure was $1.1 million, down 96.49% from the prior year.
• Share-based Compensation was $9.2 million for Q1 2026 at Chemed, up from -$23.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $30.8 million in Q4 2024 to a low of -$23.3 million in Q4 2025.
• Historically, Share-based Compensation has averaged $4.3 million across 5 years, with a median of $8.4 million in 2023.
• Biggest YoY gain for Share-based Compensation was 299.05% in 2024; the steepest drop was 402.38% in 2024.
• A 5-year view of Share-based Compensation shows it stood at -$18.2 million in 2022, then surged by 142.4% to $7.7 million in 2023, then surged by 299.05% to $30.8 million in 2024, then tumbled by 175.61% to -$23.3 million in 2025, then surged by 139.78% to $9.2 million in 2026.
• The last three Share-based Compensation figures came in at $9.2 million (Q1 2026), -$23.3 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.